Adipotide (FTPP) 10mg

Adipotide 10mg is a synthetic research peptide also known as FTPP (Fat-Targeting Proapoptotic Peptide) investigated in experimental biological models for its interaction with adipose tissue–associated vascular markers and receptor-mediated targeting pathways. In controlled laboratory environments, Adipotide 10mg is studied for its structural affinity to specific receptors expressed in white adipose tissue vasculature under preclinical research conditions. MOTS-c is often studied alongside AICAR in metabolic research models.

As a chimeric peptide compound, Adipotide 10mg has been evaluated in experimental systems exploring targeted peptide delivery strategies and tissue-selective molecular interactions. Research protocols focus on understanding how peptide-based compounds may bind to adipose-associated endothelial markers and initiate downstream intracellular signaling responses in laboratory model organisms.

Research Overview

Adipotide 10mg has been examined in preclinical investigations analyzing adipose tissue vascular targeting mechanisms and peptide-induced signaling pathways. Scientific interest in this compound centers on its structure–activity relationship and its ability to selectively bind to receptors associated with adipose tissue blood vessels in controlled experimental settings.

Laboratory research involving Adipotide 10mg typically evaluates receptor-binding specificity, molecular targeting accuracy, and intracellular pathway activation following receptor interaction. Studies are conducted under strictly regulated laboratory conditions using validated experimental models designed to assess peptide-mediated vascular responses.

In these research environments, Adipotide 10mg serves as a reference compound for investigating adipose-associated receptor expression and selective tissue targeting behavior. Experimental observations contribute to a broader understanding of peptide-based targeting systems and tissue-specific molecular signaling.

Mechanism of Study

The mechanism of study for Adipotide 10mg involves analysis of receptor-mediated binding interactions within adipose tissue–associated vasculature. Research models explore how the peptide interacts with prohibitin receptors expressed in endothelial cells of white adipose tissue.

Upon receptor binding in experimental models, downstream signaling cascades may be evaluated to observe potential apoptotic or regulatory responses within adipose-associated vascular systems. These studies are performed exclusively for laboratory research purposes to better understand targeted peptide mechanisms.

Investigators frequently examine peptide stability, receptor affinity, and intracellular signaling responses when analyzing Adipotide 10mg in controlled biological systems. Research designs emphasize reproducibility, molecular specificity, and peptide sequence integrity during experimental procedures.

Product Specifications

• 10mg per vial
• Lyophilized powder for enhanced stability
• ≥99% HPLC verified purity
• Independently tested for quality assurance
• Research use only
• Store at -20°C prior to reconstitution

Adipotide 10mg is supplied in lyophilized form to preserve molecular stability during storage and transit. Proper laboratory handling protocols are recommended to maintain peptide integrity prior to experimental preparation.

Certificate of Analysis

Each batch of Adipotide 10mg undergoes independent analytical verification to confirm purity and structural consistency. High-Performance Liquid Chromatography (HPLC) testing confirms ≥99% purity prior to distribution for research purposes.

Additional analytical characterization methods may include mass spectrometry and chromatographic validation procedures designed to confirm peptide sequence accuracy and molecular uniformity. Certificates of Analysis may be available upon request for laboratory documentation requirements.

Laboratory Handling & Storage

Adipotide 10mg should be stored in a controlled laboratory environment at -20°C to maintain structural integrity over extended storage periods. Lyophilized peptide compounds are designed to retain stability when handled according to validated laboratory guidelines.

Upon reconstitution, investigators typically follow established peptide preparation and storage protocols to minimize degradation and ensure analytical consistency. Sterile laboratory technique and temperature-controlled storage conditions are recommended throughout experimental handling procedures.

Analytical Characterization

Adipotide 10mg is characterized using validated chromatographic and molecular analytical techniques to verify peptide sequence integrity and purity levels. HPLC analysis is utilized to confirm purity specifications prior to research distribution.

In controlled research settings, mass spectrometry and peptide mapping procedures may also be employed to confirm molecular weight consistency and structural accuracy. These analytical methods support batch reliability and reproducibility within laboratory studies.

Frequently Asked Questions

Q: Is Adipotide 10mg intended for human consumption?
A: No. This compound is strictly intended for laboratory research use only.

Q: What does FTPP stand for?
A: FTPP refers to Fat-Targeting Proapoptotic Peptide, a research designation used in experimental biological models.

Q: How is purity verified?
A: Purity is confirmed through validated High-Performance Liquid Chromatography (HPLC) testing procedures.

Q: How is Adipotide 10mg supplied?
A: The compound is supplied as a lyophilized powder to preserve stability during storage and shipping.

For research use only. Not for human consumption.